Advanced
search

Search results

1 – 3 of 3
View access options
Expert briefing
Publication date: 28 November 2018
Expert Briefings Powered by Oxford Analytica

She was originally appointed in April when Thad Cochran resigned and will serve to January 2021. The win means the Republicans will have 53 Senate seats for 2019-21, a net gain of…

Details

DOI: 10.1108/OXAN-DB240212

ISSN: 2633-304X

Keywords

Geographic
United States
NA
Topical
politics
election
legislation
opposition
party
foreign trade
health
infrastructure
judicial
pharmaceutical
security
View access options
Expert briefing
Publication date: 2 August 2019
Expert Briefings Powered by Oxford Analytica

The communication is emblematic of the US Ireland political lobby and its concern about Brexit, Ireland and US-UK ties.
View access options
Executive summary
Publication date: 4 February 2019
Expert Briefings Powered by Oxford Analytica

UNITED STATES: Speech will be high on symbolism

Access

Year

Content type

Refine By Country
{"C":[{"count":"1","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Canada%22"},{"count":"2","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22China%22"}],"I":[{"count":"1","title":"Iran","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Iran%22"},{"count":"1","title":"Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Ireland%22"}],"M":[{"count":"1","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Mexico%22"}],"N":[{"count":"1","title":"North Korea","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22North+Korea%22"},{"count":"1","title":"Northern Ireland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Northern+Ireland%22"}],"R":[{"count":"1","title":"Russia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Russia%22"}],"U":[{"count":"1","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"3","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22security%22+AND+keyword-topical%3A%22foreign+trade%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 3 of 3
Manage cookies

We’re listening — tell us what you think

Join us on our journey